STOCK TITAN

Berenson Acquisition Corp. I - $BACA STOCK NEWS

Welcome to our dedicated page for Berenson Acquisition I news (Ticker: $BACA), a resource for investors and traders seeking the latest updates and insights on Berenson Acquisition I stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Berenson Acquisition I's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Berenson Acquisition I's position in the market.

Rhea-AI Summary
Berenson Acquisition Corp. I received a notice of non-compliance from NYSE due to a late filing of its Form 10-K for 2023. The company is now subject to monitoring and potential delisting if the issue is not resolved within the specified time frames. Berenson reaffirms its commitment to regaining compliance with NYSE listing standards.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Berenson Acquisition Corp. I (NYSE American: BACA) received a notice from NYSE Regulation stating that the company is not currently in compliance with the minimum public shareholders requirement. The company has 30 days to respond with a plan to regain compliance by September 30, 2024. If the plan is accepted, the company's Class A common stock is expected to continue to be listed and traded on the NYSE American LLC.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Custom Health Inc. (BACA) and Berenson Acquisition Corp. I join forces to redefine healthcare landscape, focusing on serving poly-med patients with chronic conditions. Custom Health provides a comprehensive technology-enabled medication management and managed care solution, resulting in 98% medication adherence for its patients across the United States and Canada. The Company is led by CEO, Shane Bishop, and Chairman, Rahul Chopra, who collectively bring over 30 years of central-fill pharmacy operating and management experience.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.2%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.4%
Tags
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Berenson Acquisition Corp. I

NYSE:BACA

BACA Rankings

BACA Stock Data

83.40M
779.76k
73.66%
36.89%
0.07%
Shell Companies
Financial Services
Link
United States of America
NEW YORK